TomoTherapy Incorporated announced that King Faisal Specialist Hospital & Research Centre (KFSH&RC) in Riyadh, will become the region’s first to treat patients with the Hi•Art treatment system. It is a next-generation radiation therapy solution designed to improve the precision of cancer care. KFSH&RC commemorated the historic Hi•Art treatment system installation during a scientific meeting held at the hospital. The meeting, entitled “Innovative Approaches in Radiotherapy: Beyond Tomorrow”, attracted radiation oncology professionals from throughout the country and featured an impressive roster of speakers, including TomoTherapy co-founder and Chairman of the Board Thomas “Rock” Mackie, Ph.D. “It was an honor for me to attend both the scientific meeting and Hi•Art system opening ceremony hosted by King Faisal Specialist Hospital & Research Centre,” said Dr. Mackie. “TomoTherapy is extremely pleased to partner with this world-renowned centre as it implements the only solution designed to deliver on the promises of image-guided, intensity-modulated radiation therapy (IG-IMRT).” TomoTherapy’s Hi•Art treatment system is unique among radiation therapy devices in its computed tomography (CT) scanner-based design. The system allows clinicians to efficiently acquire a true CT image of the patient immediately before daily treatment to help ensure accuracy. Then, using the same equipment as used in imaging, the treatment team can deliver highly-precise radiation in a continuous, 360-degree (helical) pattern. “We look forward to employing TomoTherapy treatment technology to benefit our patients in terms of minimization of dose to normal tissue and improvement of side-effect related outcomes,” said Dr. Mohammad Al-Shabanah, Section Head, Radiation Oncology, KFSH&RC. “One area of interest for us is the use of total marrow irradiation to support our large bone marrow transplant program.”